批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/11/06 |
SUPPL-31(补充) |
Approval |
Manufacturing (CMC) |
N/A
|
|
|
2022/04/27 |
SUPPL-29(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/02/10 |
SUPPL-27(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/08/02 |
SUPPL-25(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/12/04 |
SUPPL-22(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/05/01 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/11/05 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/04/02 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/11/21 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/05/31 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/05/31 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/04/07 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/08/12 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1997/02/17 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:IDARUBICIN HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:1MG/ML 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
050734 |
001 |
NDA |
IDAMYCIN PFS |
IDARUBICIN HYDROCHLORIDE |
INJECTABLE;INJECTION |
1MG/ML |
Prescription |
Yes |
Yes |
AP |
1997/02/17
|
PFIZER |
065036 |
001 |
ANDA |
IDARUBICIN HYDROCHLORIDE |
IDARUBICIN HYDROCHLORIDE |
INJECTABLE;INJECTION |
1MG/ML |
Prescription |
No |
No |
AP |
2002/05/01
|
MEITHEAL |
065275 |
001 |
ANDA |
IDARUBICIN HYDROCHLORIDE |
IDARUBICIN HYDROCHLORIDE |
INJECTABLE;INJECTION |
1MG/ML |
Prescription |
No |
No |
AP |
2006/12/14
|
HIKMA |
065288 |
001 |
ANDA |
IDARUBICIN HYDROCHLORIDE |
IDARUBICIN HYDROCHLORIDE |
INJECTABLE;INJECTION |
1MG/ML |
Prescription |
No |
No |
AP |
2007/05/15
|
HIKMA |